These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21040731)

  • 1. Modelling the epidemiology of hepatitis B in New Zealand.
    Mann J; Roberts M
    J Theor Biol; 2011 Jan; 269(1):266-72. PubMed ID: 21040731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
    Thornley S; Bullen C; Roberts M
    J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses.
    Dalekos GN; Zervou E; Karabini F; Tsianos EV
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):553-8. PubMed ID: 7552639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the transmission dynamics and control of hepatitis B virus in China.
    Zou L; Zhang W; Ruan S
    J Theor Biol; 2010 Jan; 262(2):330-8. PubMed ID: 19822154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.
    Park NH; Chung YH; Lee HS
    Intervirology; 2010; 53(1):20-8. PubMed ID: 20068337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B in Poland in 2001].
    Kuszewski K; Czarkowski MP
    Przegl Epidemiol; 2003; 57(1):117-23. PubMed ID: 12926317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela.
    Duarte MC; Cardona N; Poblete F; González K; García M; Pacheco M; Botto C; Pujol FH; Williams JR
    Trop Med Int Health; 2010 Aug; 15(8):924-33. PubMed ID: 20561309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatitis B for travelers: is vaccination for all travelers really necessary?
    Sonder GJ; van Rijckevorsel GG; van den Hoek A
    J Travel Med; 2009; 16(1):18-22. PubMed ID: 19192123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B in Poland in 2000].
    Kuszewski K; Swiderska H
    Przegl Epidemiol; 2002; 56(2):319-23. PubMed ID: 12371366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A
    Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States.
    Mahoney FJ; Stewart K; Hu H; Coleman P; Alter MJ
    Arch Intern Med; 1997 Dec 8-22; 157(22):2601-5. PubMed ID: 9531229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.